These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 18657909

  • 1. Chemotherapy for recurrent cervical cancer.
    Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E.
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
    Fiorica J, Holloway R, Ndubisi B, Orr J, Grendys E, Boothby R, DeCesare S, LaPolla J, Hoffman M, Patel J.
    Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy for recurrent cervical carcinoma.
    Moore DH.
    Curr Opin Oncol; 2006 Sep; 18(5):516-9. PubMed ID: 16894302
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy for recurrent cervical cancer.
    Cadron I, Van Gorp T, Amant F, Leunen K, Neven P, Vergote I.
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S113-8. PubMed ID: 17804044
    [Abstract] [Full Text] [Related]

  • 5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 6. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
    Moore KN, Herzog TJ, Lewin S, Giuntoli RL, Armstrong DK, Rocconi RP, Spannuth WA, Gold MA.
    Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X, Hu W, Ramirez PT, Kavanagh JJ.
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [Abstract] [Full Text] [Related]

  • 8. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
    Kastritis E, Bamias A, Efstathiou E, Gika D, Bozas G, Zorzou P, Sarris K, Papadimitriou C, Dimopoulos MA.
    Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J, Haensgen G.
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [Abstract] [Full Text] [Related]

  • 10. Management of metastatic cervical cancer: review of the literature.
    Long HJ.
    J Clin Oncol; 2007 Jul 10; 25(20):2966-74. PubMed ID: 17617528
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma.
    Tiersten AD, Selleck MJ, Hershman DL, Smith D, Resnik EE, Troxel AB, Brafman LB, Shriberg L.
    Gynecol Oncol; 2004 Feb 10; 92(2):635-8. PubMed ID: 14766258
    [Abstract] [Full Text] [Related]

  • 12. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study.
    Piver MS, Ghamande SA, Eltabbakh GH, O'Neill-Coppola C.
    Gynecol Oncol; 1999 Dec 10; 75(3):334-7. PubMed ID: 10600285
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy in the management of cervical carcinoma.
    duPont NC, Monk BJ.
    Clin Adv Hematol Oncol; 2006 Apr 10; 4(4):279-86. PubMed ID: 16728939
    [Abstract] [Full Text] [Related]

  • 14. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
    Kastritis E, Bamias A, Bozas G, Koutsoukou V, Voulgaris Z, Vlahos G, Rodolakis A, Gika D, Papadimitriou C, Dimopoulos MA.
    Gynecol Oncol; 2007 Feb 10; 104(2):372-6. PubMed ID: 17030353
    [Abstract] [Full Text] [Related]

  • 15. The role of paclitaxel in the management of patients with carcinoma of the cervix.
    Thigpen T, Vance R, Khansur T, Malamud F.
    Semin Oncol; 1997 Feb 10; 24(1 Suppl 2):S2-41-S2-46. PubMed ID: 9045336
    [Abstract] [Full Text] [Related]

  • 16. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 10; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    Long HJ, Bundy BN, Grendys EC, Benda JA, McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV, Gynecologic Oncology Group Study.
    J Clin Oncol; 2005 Jul 20; 23(21):4626-33. PubMed ID: 15911865
    [Abstract] [Full Text] [Related]

  • 18. Salvage chemotherapy in recurrent cervical cancer with biweekly pegylated liposomal Doxorubicin (lipo-dox).
    Chen JR, Yang YC, Chen TC, Lai JC, Chang SJ, Chang CL, Wang KL.
    Taiwan J Obstet Gynecol; 2008 Sep 20; 47(3):322-6. PubMed ID: 18935997
    [Abstract] [Full Text] [Related]

  • 19. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS, Filiaci VL, Thigpen JT, Gallion HH, Fleming GF, Rodgers WH, Gynecologic Oncology Group study.
    Gynecol Oncol; 2007 Jul 20; 106(1):16-22. PubMed ID: 17574073
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancer.
    Nagata N, Kobayashi M, Kojima H, Kondo K, Hirabayashi N, Matsui T, Kataoka M, Takiyama W, Miyashita Y, Nakazato H, Araki K, Itoh H, Nakao A, Sakamoto J.
    Hepatogastroenterology; 2005 Jul 20; 52(66):1905-10. PubMed ID: 16334804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.